Fox Chase Cancer Center News

PHILADELPHIA (January 19, 2024) — Although studies have shown that aspirin can reduce the risk for colon cancer among people with Lynch syndrome, a new study presented today by researchers at Fox Chase Cancer Center found that only a minority of patients are taking it as a form of chemoprevention.

Inside every Chemo Comfort Bag is a little piece of the memory of Jerry “Herk” Hertkorn. This past year, his daughter, Fox Chase Cancer Center nurse practitioner Caryn Vadseth, MSN, CRNP , AGPCNP-BC, OCN, turned the group she created in his memory, Herk’s Heroes, into an official 501(c)3 charitable organization with the mission to provide comfort and support to cancer patients.

The Fox Chase Cancer Center ICU has not seen a patient fall in the department since the summer of 2020. It is a remarkable feat entirely due to the attention and commitment of the ICU nursing staff, says Kathleen Wolf, MBA, BSN, RN, NEA-BC, director of Magnet/Nursing Quality at Fox Chase.

A nursing mentor and her former protégé—both from Germany—reunited in the United States in mid-March 2023 to discuss the future of the nursing profession and to explore potential collaborations that will help move the profession forward.

PHILADELPHIA (January 12, 2024) — Researchers at Fox Chase Cancer Center have identified a genetic mechanism that can make small cell lung cancer tumors vulnerable to attack by the immune system.

PHILADELPHIA (January 10, 2024) — He tells people that he’s the 2.0 version of himself now, because his cancer experience so dramatically changed the way he thinks. That’s Nick Pifani, a six-year pancreatic cancer survivor whose story was the centerpiece of a special Together Facing Pancreatic Cancer on November 16 at Fox Chase Cancer Center.

PHILADELPHIA (January 10, 2024) — Local car dealer Gary Barbera (pictured, sixth from left) joined with his staff and customers in their “Kick Cancer to the Curb” campaign to support Fox Chase Cancer Center. He visited Fox Chase in December to present a check for $10,000 to Fox Chase President and CEO Robert Uzzo, MD, MBA, FACS.

Fox Chase Cancer Center was recently recognized by the ECOG-ACRIN Cancer Research Group for outstanding achievement in accrual, scientific contribution, and administrative participation.